Revvity SG&A Expenses 2010-2024 | RVTY

Revvity annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Revvity sg&a expenses for the quarter ending June 30, 2024 were $0.252B, a 5.76% decline year-over-year.
  • Revvity sg&a expenses for the twelve months ending June 30, 2024 were $1.019B, a 1.65% increase year-over-year.
  • Revvity annual sg&a expenses for 2023 were $1.023B, a 0.29% decline from 2022.
  • Revvity annual sg&a expenses for 2022 were $1.026B, a 5.16% increase from 2021.
  • Revvity annual sg&a expenses for 2021 were $0.975B, a 36.11% increase from 2020.
Revvity Annual SG&A Expenses
(Millions of US $)
2023 $1,023
2022 $1,026
2021 $975
2020 $716
2019 $815
2018 $812
2017 $626
2016 $590
2015 $587
2014 $648
2013 $582
2012 $627
2011 $624
2010 $487
2009 $477
Revvity Quarterly SG&A Expenses
(Millions of US $)
2024-06-30 $252
2024-03-31 $261
2023-12-31 $257
2023-09-30 $250
2023-06-30 $267
2023-03-31 $249
2022-12-31 $244
2022-09-30 $243
2022-06-30 $263
2022-03-31 $275
2021-12-31 $166
2021-09-30 $276
2021-06-30 $282
2021-03-31 $251
2020-12-31 $62
2020-09-30 $225
2020-06-30 $221
2020-03-31 $209
2019-12-31 $211
2019-09-30 $204
2019-06-30 $202
2019-03-31 $199
2018-12-31 $211
2018-09-30 $197
2018-06-30 $205
2018-03-31 $200
2017-12-31 $176
2017-09-30 $153
2017-06-30 $150
2017-03-31 $147
2016-12-31 $152
2016-09-30 $143
2016-06-30 $151
2016-03-31 $145
2015-12-31 $147
2015-09-30 $148
2015-06-30 $147
2015-03-31 $146
2014-12-31 $206
2014-09-30 $143
2014-06-30 $147
2014-03-31 $152
2013-12-31 $140
2013-09-30 $143
2013-06-30 $148
2013-03-31 $151
2012-12-31 $175
2012-09-30 $145
2012-06-30 $150
2012-03-31 $157
2011-12-31 $220
2011-09-30 $133
2011-06-30 $138
2011-03-31 $133
2010-12-31 $122
2010-09-30 $121
2010-06-30 $123
2010-03-31 $122
2009-12-31 $111
2009-09-30 $113
2009-06-30 $124
2009-03-31 $129
Sector Industry Market Cap Revenue
Medical Medical Services $14.682B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00